Journal Watch · Frontiers in Immunology · 2026

The spatial landscape of the peritumoral interface: ARG1<sup>+</sup> PMN-MDSCs reduction and NETosis as indicators of occult metastasis in tongue squamous cell carcinoma.

This spatial biomarker provides a high-resolution tool to optimize patient selection for elective neck dissection.

Zhang S, Xu J, Zhang C et al.Frontiers in Immunology3 min readPharma relevance 40/100

DOI: 10.3389/fimmu.2026.1910935PMID: 42688240Study type: research study

TL;DR

This spatial biomarker provides a high-resolution tool to optimize patient selection for elective neck dissection.

Key findings

  • This localized cellular loss inversely correlated with an accumulation of neutrophil extracellular traps (NETs) at the peritumoral interface, indicating that ARG1<sup>+</sup> PMN-MDSC-associated spatial alterations coincide with NET-associated remodeling at the peritumoral interface.
  • Integrating the intrastromal density of ARG1<sup>+</sup> PMN-MDSCs with depth of invasion significantly enhanced the diagnostic accuracy for occult metastasis (Area Under the Curve = 0.8318) compared to using depth of invasion alone.<h4>Conclusions</h4>Early metastatic risk is driven by localized alterations within the myeloid compartment, characterized by the transition of intact ARG1<sup>+</sup> PMN-MDSCs to NETs within a 35-μm peritumoral hotspot.
  • This spatial biomarker provides a high-resolution tool to optimize patient selection for elective neck dissection.

What they did

A novel "Spatial Availability Index" was applied to map cellular distribution, and diagnostic performance was evaluated using receiver operating characteristic curve analysis.<h4>Results</h4>Arginase-1 (ARG1) was identified as a top candidate biomarker, exhibiting a unique "tissue-low, serum-high" expression pattern in cases with occult metastasis. Spatial analysis revealed a significant depletion of ARG1<sup>+</sup> polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in both primary tumors and paired lymph nodes during metastatic progression. Specifically, the reduction of these intact cells was most pronounced within a 35-μm proximal segment from the tumor boundary.

Full abstract (original)

Background: <h4>Background</h4>Predicting occult lymph node metastasis in early-stage tongue squamous cell carcinoma remains a clinical challenge because traditional markers, such as depth of invasion, exhibit limited accuracy. This study aimed to identify spatial immunological biomarkers to improve risk stratification and clinical decision-making.<h4>Methods</h4>Olink proteomic profiling was conducted to screen for metastasis-associated biomarkers. Subsequently, multiplex immunofluorescence coupled with artificial intelligence-powered spatial analysis was utilized to evaluate the microenvironment in primary lesions and paired cervical lymph nodes.

What they did: A novel "Spatial Availability Index" was applied to map cellular distribution, and diagnostic performance was evaluated using receiver operating characteristic curve analysis.<h4>Results</h4>Arginase-1 (ARG1) was identified as a top candidate biomarker, exhibiting a unique "tissue-low, serum-high" expression pattern in cases with occult metastasis. Spatial analysis revealed a significant depletion of ARG1<sup>+</sup> polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) in both primary tumors and paired lymph nodes during metastatic progression. Specifically, the reduction of these intact cells was most pronounced within a 35-μm proximal segment from the tumor boundary.

Results & conclusions: This localized cellular loss inversely correlated with an accumulation of neutrophil extracellular traps (NETs) at the peritumoral interface, indicating that ARG1<sup>+</sup> PMN-MDSC-associated spatial alterations coincide with NET-associated remodeling at the peritumoral interface. Integrating the intrastromal density of ARG1<sup>+</sup> PMN-MDSCs with depth of invasion significantly enhanced the diagnostic accuracy for occult metastasis (Area Under the Curve = 0.8318) compared to using depth of invasion alone.<h4>Conclusions</h4>Early metastatic risk is driven by localized alterations within the myeloid compartment, characterized by the transition of intact ARG1<sup>+</sup> PMN-MDSCs to NETs within a 35-μm peritumoral hotspot. This spatial biomarker provides a high-resolution tool to optimize patient selection for elective neck dissection.

Abstract © the authors / Frontiers in Immunology (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.3389/fimmu.2026.1910935 · PubMed 42688240.

Why it matters for pharma & biotech

  • Directly relevant to teams in AI in drug discovery / diagnostics — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: AI in drug discovery / diagnostics

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Frontiers in Immunology study find?

This spatial biomarker provides a high-resolution tool to optimize patient selection for elective neck dissection.

What type of study is this?

It is a research study, published in Frontiers in Immunology in 2026. A novel "Spatial Availability Index" was applied to map cellular distribution, and diagnostic performance was evaluated using receiver operating characteristic curve analysis.<h4>Results</h4>Arginase-1 (ARG1) was identified as a top candidate biomarker, exhibiting a unique "tissue-low, serum-high" expression pattern in cases with occult metastasis.

Where can I read the original paper?

The original is at the publisher via DOI 10.3389/fimmu.2026.1910935. PubMed ID: 42688240. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zhang S, Xu J, Zhang C et al.. The spatial landscape of the peritumoral interface: ARG1&lt;sup&gt;+&lt;/sup&gt; PMN-MDSCs reduction and NETosis as indicators of occult metastasis in tongue squamous cell carcinoma.. Frontiers in Immunology (2026). DOI: 10.3389/fimmu.2026.1910935.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/the-spatial-landscape-of-the-peritumoral-interface-arg1-lt-sup-gt-lt-sup-910935/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides